overcoming resistance in egfr nsclc - lung cancer onctalk 2022
Published 1 year ago • 132 plays • Length 10:16Download video MP4
Download video MP3
Similar videos
-
4:10
overcoming resistance in alk or kras nsclc - lung cancer onctalk 2022
-
3:46
overcoming resistance in ros1 , ret , or braf nsclc - lung cancer onctalk 2022
-
6:58
strategies to overcome resistance - lung cancer onctalk 2022
-
3:02
resistance mechanisms in egfr nsclc treatment - targeted therapies in lung cancer 2023
-
2:30
acquired resistance to osimertinib in egfr nsclc - 2022 program: targeted therapies forum - english
-
4:02
treatment of egfr mutated nsclc - 2022 program: targeted therapies forum - english
-
3:14
advancements of targeted therapy for egfr mutations in nsclc
-
3:20
egfr mutated nsclc disease progression on osimertinib - 2022 program: targeted therapies forum
-
4:26
combinations and other options for acquired resistance in egfr mutation-positive nsclc
-
1:24
checkmate 77t: perioperative nivolumab in nsclc - onctalk lung 2023
-
4:10
egfr mutations in advanced nsclc - targeted therapies in lung cancer 2023
-
6:20
oncogene-driven metastatic nsclc: frontline treatment & resistance mechanisms - onctalk 2022
-
2:26
patterns of acquired resistance to egfr tkis in egfr mutation-positive nsclc
-
6:26
metastatic egfr nsclc: recent developments - targeted therapies in lung cancer 2023
-
2:43
post-osimertinib treatment options for egfr nsclc - targeted therapies in lung cancer 2023
-
1:26
first line treatment of egfr mutation-positive nsclc
-
28:22
gracecast-088_lung-cancer_challenging cases in lung cancer: acquired resistance to egfr tki therapy
-
7:35
treatment for patients with egfr nsclc - leading developments & current questions in lung cancer
-
7:48
should avastin be added to egfr tki therapy for egfr mutation-positive nsclc?